Announcement on Obtaining Drug Registration Certificate
Filed with SSE · · 3 pages · Chinese
North China Pharmaceutical Company Ltd. on 6ix
Earlier from North China Pharmaceutical
- Announcement on Implementation of Dividend Distribution for 2025
- Announcement on Election of Employee Director
- Announcement on Convening Performance Briefing for 2025 and Q1 2026
- Announcement on Release of Pledge and Pledge of Some Shares of Shareholders
- Notice on Convening the 2025 Annual General Meeting
Later from North China Pharmaceutical
- Announcement on Inclusion of Products of the Company and Its Subsidiaries in the National Essential Medicines List
- Announcement on the Proposed Selection of Drugs of the Company and Its Subsidiaries in the National Centralized Drug Procurement
- Announcement on Resignation of Senior Management
- Semi-annual Report for 2026
- Announcement on Obtaining Notice of Approval for Drug Supplementary Application by a Subordinate Company
Follow North China Pharmaceutical into a list and get an email when it puts out news.
Follow North China Pharmaceutical